Table 2 Direct medical, non-medical and indirect costs in included studies
From: Subjective and objective financial toxicity among colorectal cancer patients: a systematic review
Author, Year | Country | Stage of Cancera | Year of Research | No. of patientsb | Direct medical cost | Direct non-medical | indirect cost | Perspective |
|---|---|---|---|---|---|---|---|---|
Malaysia | all stages | 2013 | 138 | RM 6544.5 (USD 2045.1) for stage I, RM 7790.1 (USD 2434.4) for stage II, RM 8799.1 (USD 2749.7) for stage III and RM 8638.2 (USD 2699.4) for stage IV | NA | USD 452.2 | Patient | |
O Céilleachair et al. 2017 [30] | Ireland | all stages | October 2007–September 2009 | 497 | Average OOP: €1589 (USD 2192.8) among colorectal cancer survivors | €510(USD703.8) | NA | Patient |
Seifeldin & Hantsch 1999 [23] | USA | all stages | 1991–1994 | The mean number of admissions: 237,754 per year | Total hospital charge is USD 4.5 billion per year (4 years period) | NA | NA | National HC |
Huang et al. 2017 [25] | China | all stages | September 2012 to December 2014 | 2356 | 51,366 CNY (USD 8,284.8) for stage I to 75,673 CNY (USD 12,205.3) for stage IV disease | 5588 CNY(USD 901.2) per CRC patient | mean wage loss amounted to 6652 CNY (USD 1,072.9). | Patient and health insurance |
Li et al. 2016 [26] | China | Not mentioned | January to December 2013 | 1211 | USD 757,432.26 | NA | NA | new Rural Cooperative Medical Scheme (NCMS) |